| Authors: |
Fraslin AM; Biostatistics and Epidemiology Unit, Gustave Roussy, Oncostat 1018 INSERM, labeled Ligue Contre le Cancer, University Paris-Saclay, Villejuif, France. Electronic address: alderic.fraslin@gustaveroussy.fr., Aupérin A; Biostatistics and Epidemiology Unit, Gustave Roussy, Oncostat 1018 INSERM, labeled Ligue Contre le Cancer, University Paris-Saclay, Villejuif, France., Even C; Department of Head and Neck Oncology, Gustave Roussy, Villejuif, France., Fayette J; Department of Medical Oncology, University of Lyon, Centre Léon Bérard, Lyon, France., Saada-Bouzid E; Department of Medical Oncology, Centre Antoine Lacassagne, University Côte d'Azur, Nice, France., Lafond C; Department of Medical Oncology, ILC Centre Jean Bernard/Clinique Victor Hugo, Le Mans, France., Geoffrois L; Department of Medical Oncology, Institut de Cancérologie de Lorraine, Nancy, France., Bourhis J; Lausanne University Hospital, Lausanne, Switzerland., Guigay J; Department of Head and Neck Oncology, Gustave Roussy, Villejuif, France., Bonastre J; Biostatistics and Epidemiology Unit, Gustave Roussy, Oncostat 1018 INSERM, labeled Ligue Contre le Cancer, University Paris-Saclay, Villejuif, France. |